Abstract:Deregulated translation plays an important role in human cancer. We previously reported decreased eukaryotic initiation factor 3 subunit f (eIF3f) expression in pancreatic cancer. Whether decreased eIF3f expression can transform normal epithelial cells is not known. In our current study, we found evidence that stable knockdown of eIF3f in normal human pancreatic ductal epithelial cells increased cell size, nuclear pleomorphism, cytokinesis defects, cell proliferation, clonogenicity, apoptotic resistance, migration, and formation of 3-dimensional irregular masses. Our findings support the tumor suppressive role of eIF3f in pancreatic cancer. Mechanistically, we found that eIF3f inhibited both cap-dependent and cap-independent translation. An increase in the ribosomal RNA (rRNA) level was suggested to promote the generation of cancer. The regulatory mechanism of rRNA degradation in mammals is not well understood. We demonstrated here that eIF3f promotes rRNA degradation through direct interaction with heterogeneous nuclear ribonucleoprotein (hnRNP) K. We showed that hnRNP K is required for maintaining rRNA stability: under stress conditions, eIF3f dissociates hnRNP K from rRNA, thereby preventing it from protecting rRNA from degradation. We also demonstrated that rRNA degradation occurred in non-P body, non-stress granule cytoplasmic foci that contain eIF3f. Our findings established a new mechanism of rRNA decay regulation mediated by hnRNP K/eIF3f and suggest that the tumor suppressive function of eIF3f may link to impaired rRNA degradation and translation.

Translation initiation factor eIF3a regulates glucose metabolism and cell proliferation via promoting small GTPase Rheb synthesis and AMPK activation

Translational Regulator Eif2α in Tumor

eIF3i promotes colorectal cancer cell survival via augmenting PHGDH translation

Eif3a Mediates HIF1α-dependent Glycolytic Metabolism in Hepatocellular Carcinoma Cells Through Translational Regulation.

Elevated Nuclear Phospho-Eif4e Body Levels Are Associated with Tumor Progression and Poor Prognosis for Acute Myeloid Leukemia

eIF3i activity is critical for endothelial cells in tumor induced angiogenesis through regulating VEGFR and ERK translation.

Eukaryotic Translation Initiation Factor 3 and Tumor

eIF3a Regulates Colorectal Cancer Metastasis via Translational Activation of RhoA and Cdc42

eIF3 mRNA selectivity profiling reveals eIF3k as a cancer-relevant regulator of ribosome content

eIF3a regulation of mTOR signaling and translational control via HuR in cellular response to DNA damage

Translation initiation factors and abnormalities of translation control in tumors

Downregulation Of Eukaryotic Translation Initiation Factor 3b Inhibited Proliferation And Metastasis Of Gastric Cancer

eIF3i regulation of protein synthesis, cell proliferation, cell cycle progression, and tumorigenesis

Eif3 Regulation of Protein Synthesis, Tumorigenesis, and Therapeutic Response.

mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3 -mediated non-degradative ubiquitination of eIF4A1

eIF3a: A new anticancer drug target in the eIF family.

The Tumor Suppressive Role of eIF3f and Its Function in Translation Inhibition and rRNA Degradation

mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3 IBTK -mediated ubiquitination of eIF4A1 in cancer cells

Research progress on eIF3 a and cancer

eIF4E S209 phosphorylation licenses Myc-and stress-driven oncogenesis

Eukaryotic Translation Initiation Factor 3b is Both a Promising Prognostic Biomarker and a Potential Therapeutic Target for Patients with Clear Cell Renal Cell Carcinoma.